Virology
Recent findings illuminate research in virology
Published in Hepatitis Weekly, May 16th, 2005
Study 1: Hepatitis C virus isolates exhibit NS3 protease heterogeneity.
According to a study from France, "NS3 protease is essential for hepatitis C Virus (HCV) replication, and is one of the most promising targets for specific anti-HCV therapy. Its natural polymorphism has not been studied at the quasispecies level. In the present work, the genetic heterogeneity of the NS3 protease gene was analyzed in 17 HCV genotype 1 (5 subtypes 1a and 12 subtypes 1b) samples collected from infected patients before anti-viral therapy."
"A total of 294...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-05-16)
More Articles from Hepatitis Weekly
- Diagnostics
Optical fiber immunosensor detects antibodies to hepatitis C virus antigen - Liver Cancer
Mutant p53 allows hepatitis C virus core-expressing cells to develop cancer - Liver Transplantation
A simple noninvasive index predicts fibrosis in HCV-infected liver recipients - Stem Cell Research
Stem cell transplantation reactivates resolved hepatitis B infection - Transplant Medicine
Mcm-2 predicts fibrosis progression after HCV-related liver transplantation - Addiction Medicine
Medical exams before drug abuse treatment open avenues for hepatitis screening - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
